A common misconception behind the authenticity of operations of an e-pharmacy is prevalent because there is skeptical knowledge behind the legal business modelsvis a vis the illegal international trade of drugs online
Read MoreThe portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said
Read MoreGovernment is considering a proposal to relax foreign direct investment norms in existing pharmaceutical companies with a view to attracting more overseas inflows
Read MoreSun Pharma has not only violated the good corporate governance in terms of transparency but also consciously tried to make the investors believe that there is no plan to either divest assets or to cut jobs by strongly denying the then true media reports
Read MoreThe world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product
Read MoreCapping the price of a device is counter-productive - it will halt research and innovation and won't benefit the patient; the cost of the device such as stent is a mere fraction of the total cost of the procedure required for its implantation
Read MoreIn a partnership that will look to address the need of the hour, Tata Trusts will invest its strategic knowhow in the realm of healthcare in the state
Read MoreBig industry names participating in the BW Healthcare Summit were unanimous in their view that the country held huge untapped opportunities for healthcare services
Read More